Net Income

Ag-tech leader Carbon Robotics surpasses $100M in revenue, appoints a new CFO, and solidifies its global leadership in AI-driven sustainable farming.

HVAC giant Daikin partners with AI startup Outerport, turning legacy blueprints into intelligent data to accelerate the future of manufacturing.

Biotech firm Humacyte raises $20M to accelerate sales of its FDA-approved Symvess® and fund crucial trials for new hemodialysis applications.

With US household debt at a record $18.8 trillion, Austin-based Avtal lands $24M to bring compliance and digital tools to a legacy industry.

Hamilton Lane and CenterSquare partner on a Las Vegas shopping center, a deal highlighting institutional capital's growing appetite for essential retail.

With pivotal trials advancing, key FDA alignment, and a strong cash position, Taysha Gene Therapies charts a clear path toward a potential breakthrough.

A new initiative promises to pay farmers for regenerative practices while offering corporations verifiable climate assets. Can it fix the troubled carbon market?

Amidst record sales but widening losses, the Vietnamese automaker is overhauling its strategy, betting on smart factories and AI to carve out a profitable future.

Hippo's tech-driven home insurance is now on Progressive's platform in 8 states, a strategic play for scale and improved financial performance.

Creative Homes breaks ground on a luxury home in Lake Elmo, with all proceeds funding St. Jude's fight against childhood cancer. A house built on hope.

A leading firearms maker partners with the National Forest Foundation, linking special edition rifle sales to reforestation and wildlife restoration projects.

Annovis Bio's new trial for buntanetap uses an AI-powered Apple Watch app to track symptoms, aiming for more precise data in the race for a cure.

With a new CEO driven by a personal mission, Cylinder Health aims to scale its virtual care model in the booming, high-cost digestive health market.

Sylogist reports strong SaaS revenue growth but an overall revenue decline and net loss, highlighting the high stakes of its ongoing business transformation.

A novel blood test from C2N Diagnostics, used in a major Alzheimer's trial, shows promise in predicting disease progression, heralding a new era of precision medicine.

The Ontario Real Estate Association is calling for a radical overhaul of development charges to tackle housing affordability. Will it work?

The toy giant's 600,000-square-foot facility is more than a warehouse; it's a key move in its plan for faster delivery and supply chain dominance.

A new biotech spins out with a novel drug class aiming to provide healthier, more durable weight loss and combat cancer-related wasting syndrome.

A new drug shows unprecedented activity against all common cold viruses, a major breakthrough for millions suffering from chronic lung diseases.

The equipment dealer exceeded its inventory reduction goals but faces a net loss and a grim forecast amid a broader agricultural market slump.